PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

被引：0
|
作者：
Karin Beelen
Mark Opdam
Tesa M Severson
Rutger HT Koornstra
Andrew D Vincent
Jelle Wesseling
Jettie J Muris
Els MJJ Berns
Jan B Vermorken
Paul J van Diest
Sabine C Linn
机构：
[1] The Netherlands Cancer Institute,Departments of Molecular Biology
[2] The Netherlands Cancer Institute,Departments of Biometrics
[3] The Netherlands Cancer Institute,Departments of Pathology
[4] Erasmus University Medical Center- Cancer Center,Department of Medical Oncology
[5] Antwerp University Hospital,Department of Medical Oncology
[6] University Medical Center Utrecht,Department of Pathology
[7] The Netherlands Cancer Institute,Departments of Medical Oncology
来源：
Breast Cancer Research | / 16卷
关键词：
Tamoxifen; Molecular Alteration; PIK3CA Mutation; Adjuvant Tamoxifen; Endocrine Resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients
    Beelen, Karin
    Opdam, Mark
    Severson, Tesa M.
    Koornstra, Rutger H. T.
    Vincent, Andrew D.
    Wesseling, Jelle
    Muris, Jettie J.
    Berns, Els M. J. J.
    Vermorken, Jan B.
    van Diest, Paul J.
    Linn, Sabine C.
    BREAST CANCER RESEARCH, 2014, 16 (01)
  • [2] PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Rasti, Aryana R.
    Guimaraes-Young, Amy
    Datko, Farrah
    Borges, Virginia F.
    Aisner, Dara L.
    Shagisultanova, Elena
    JCO PRECISION ONCOLOGY, 2022, 6
  • [3] Analysis of PIK3CA mutations in the primary and recurrent tumors of hormone receptor positive/human epidermal growth factor receptor 2 negative breast cancer
    Wang, Yue
    Li, Xin
    Zhang, Shuang
    Liang, Li
    Xu, Ling
    Liu, Yinhua
    Li, Ting
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (09) : 1024 - 1031
  • [4] Assessment of PIK3CA Mutations in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Clinical Validity but Not Utility
    Henry, N. Lynn
    Schott, Anne F.
    Hayes, Daniel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (29) : 3207 - +
  • [5] Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells
    Nahta, R
    Yuan, LYH
    Zhang, B
    Kobayashi, R
    Esteva, FJ
    CANCER RESEARCH, 2005, 65 (23) : 11118 - 11128
  • [6] PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis
    Seo, Youjeong
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    Nam, Seok Jin
    Cho, Soo Youn
    Cho, Eun Yoon
    JOURNAL OF BREAST CANCER, 2018, 21 (04) : 382 - +
  • [7] PIK3CA Genotype and Treatment Decisions in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Cescon, David W.
    Bedard, Philippe L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (12) : 1318 - +
  • [8] PIK3CA Mutations Are Not a Major Determinant of Resistance to the Epidermal Growth Factor Receptor Inhibitor Cetuximab in Metastatic Colorectal Cancer
    Prenen, Hans
    De Schutter, Jef
    Jacobs, Bart
    De Roock, Wendy
    Biesmans, Bart
    Claes, Bart
    Lambrechts, Diether
    Van Cutsem, Eric
    Tejpar, Sabine
    CLINICAL CANCER RESEARCH, 2009, 15 (09) : 3184 - 3188
  • [9] PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer
    Majewski, Ian J.
    Nuciforo, Paolo
    Mittempergher, Lorenza
    Bosma, Astrid J.
    Eidtmann, Holger
    Holmes, Eileen
    Sotiriou, Christos
    Fumagalli, Debora
    Jimenez, Jose
    Aura, Claudia
    Prudkin, Ludmila
    Carmen Diaz-Delgado, Maria
    de la Pena, Lorena
    Loi, Sherene
    Ellis, Catherine
    Schultz, Nikolaus
    de Azambuja, Evandro
    Harbeck, Nadia
    Piccart-Gebhart, Martine
    Bernards, Rene
    Baselga, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (12) : 1334 - 1339
  • [10] Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: A supporting role to the epidermal growth factor receptor
    Knowlden, JM
    Hutcheson, IR
    Barrow, D
    Gee, JMW
    Nicholson, RI
    ENDOCRINOLOGY, 2005, 146 (11) : 4609 - 4618
12345